> Abbott ($ABT) said promising early results indicate its new diagnostic testing platform can spot life-threatening infections more quickly than current standards of care. Release
> The Broad Institute confirmed it is laying off 27 people as the National Institutes of Health stops funding for a program that created service centers to run chemical screens for laboratories nationally. Story (reg. req.)
> Veracyte ($VCYT) is rolling out a product designed to help enhance the effectiveness and use of its Afirma thyroid cancer test. Release
> Minnesota's MGC Diagnostics ($MGCD) will distribute sleep apnea diagnostic products made by Neurovirtual USA. Release
> CT texture analysis works as an imaging biomarker to help predict the survival of metastatic melanoma patients getting antiangiogenic therapy, according to a new study. Story (reg. req.)
> Berg and the Medical University of South Carolina will collaborate to discover a new lupus biomarker. Release